Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


House Subcommittee OK's FDA User Fee Bill; More Debate On Third-Party Servicers To Come

Executive Summary

The House Energy and Commerce Health Subcommittee passed a bill reauthorizing FDA's device user fees May 18, along with amendments on over-the-counter (OTC) hearing aids and to streamline agency inspections of device facilities, among others. The subpanel agreed to shelve – for now – a proposed bill to facilitate off-label communications by medical product firms, and said they will wait for the full committee markup to debate a third-party servicers bill backed by imaging firms.

You may also be interested in...

Twenty-Four Congressional Midterm Races To Watch In US Medtech-Heavy Regions

Medtech firms are accustomed to rooting for House and Senate candidates they have backed in traditionally medtech-facility heavy regions of the US including Minnesota, Indiana and Massachusetts. As the sector grows in new regions, there are a broader set of important races for the industry, including in California, Texas, and New Jersey, this election season.

House Committee Advances User Fees With Full Slate Of Device Amendments

House Energy and Commerce Committee members added a slate of industry-favored device amendments into the FDA Reauthorization Act before sending the bill to the chamber floor, including reforms targeting device accessories, medical imaging and post-market surveillance.

User-Fee Bill Advances With Broad Support, Additional Device Reforms

The US Senate Health, Education, Labor, and Pensions Committee approved the FDA Reauthorization Act, reauthorizing drug and device user fees and multiple additions device regulation reforms, on a 21-2 vote. The mark-up session also gave HELP members from both parties a chance to vent about provisions they'd want to see in a Senate version of an Affordable Care Act repeal bill.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts